Polymyxin B hemoperfusion and mortality in abdominal septic shock [4]

JAMA

Volumn 302, Issue 18, 2009, Pages 1969-

  Kida, Yujiro ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; POLYMYXIN B; ANTIINFECTIVE AGENT;

HEMOPERFUSION; HUMAN; LETTER; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; SURVIVAL TIME; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; NOTE;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMOPERFUSION; HUMANS; POLYMYXIN B; SHOCK, SEPTIC;

EID: 70450042814     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1608     Document Type: Letter

References (1)

1. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301(23):2445-2452.